Risultati per: Trattamento e gestione del morbo di Crohn

Methodological issues in HRQoL measurement, including the need for larger sample sizes, standardized reporting, and uniform participant characteristics, contribute to the low methodological quality of current evidence on the impact of biological agents on HRQoL in CD. There is a large unmet need to investigate the association between clinical outcomes and HRQoL outcomes more thoroughly.

Per la fase avanzata. Al San Carlo di Potenza

Studio dell’Istituto nazionale tumori su terapia non chirurgica

Studio dell’Istituto nazionale tumori su terapia non chirurgica

Tasty&Healthy (T&H) is a whole-food diet for Crohn’s disease (CD), which excludes processed food, gluten, red meat, and dairy, without requiring formula or mandatory ingredients. TASTI-MM was a clinician-blinded, randomized-controlled trial comparing tolerability and effectiveness of T&H vs. exclusive enteral nutrition (EEN).

The prevalence of Crohn disease (CD) is rising globally and therefore is of increasing relevance in the dermatology clinic. Between 14% and 44% of patients with CD demonstrate mucocutaneous involvement, which has been postulated to result from abnormal homing of gut lymphocytes to the skin.

This consensus statement establishes diagnostic criteria for metastatic cutaneous Crohn disease from a panel of experts on the disease.